IkB proteins are the primary inhibitors of NF-kB. Here, we demonstrate that sumoylated and phosphorylated IkBa accumulates in the nucleus of keratinocytes and interacts with histones H2A and H4 at the regulatory region of HOX and IRX genes. Chromatin-bound IkBa modulates Polycomb recruitment and imparts their competence to be activated by TNFa. Mutations in the Drosophila IkBa gene cactus enhance the homeotic phenotype of Polycomb mutants, which is not counteracted by mutations in dorsal/NF-kB. Oncogenic transformation of keratinocytes results in cytoplasmic IkBa translocation associated with a massive activation of Hox. Accumulation of cytoplasmic IkBa was found in squamous cell carcinoma (SCC) associated with IKK activation and HOX upregulation.
INTRODUCTION
NF-kB plays a crucial role in biological processes, such as native and adaptive immune responses, organ development, cell proliferation, apoptosis, or cancer (Naugler and Karin, 2008; Vallabhapurapu and Karin, 2009 ). NF-kB activation depends on the IKK-mediated degradation of the NF-kB inhibitors, IkB proteins, that takes place in the cytoplasm and results in the translocation of the NF-kB transcription factor to the nucleus, where it activates gene expression. Recent studies demonstrate the existence of alternative nuclear functions for regulatory elements of the pathway (reviewed in Espinosa et al., 2011) , but their biological implications remain poorly understood. Recently, it has been demonstrated that nuclear IkBb binds the promoter
Significance
Up to now, the only known function for IkBa is as a repressor of NF-kB. We now demonstrate that IkBa plays an alternative role in the chromatin through binding to histones H2A and H4 and regulation of polycomb-dependent transcriptional repression. Consistent with the functional relevance of polycomb-associated IkBa function, Cactus/IkBa deficiency affects Drosophila development. In mammals, we found that IkBa regulates keratinocyte differentiation and transformation associated with altered Hox/IRX expression. of NF-kB target genes following lipopolysaccharide (LPS) stimulation to prevent IkBa-mediated inactivation, thereby sustaining cytokine expression in immune cells (Rao et al., 2010) . Numerous studies have reported nuclear translocation of IkBa (Aguilera et al., 2004; Arenzana-Seisdedos et al., 1997; Huang and Miyamoto, 2001; Wuerzberger-Davis et al., 2011) and various partners for nuclear IkBa, including histone deacetylases (HDACs) and nuclear corepressors, have been identified (Aguilera et al., 2004; Espinosa et al., 2003; Viatour et al., 2003) . In fibroblasts, nuclear IkBa associates with the promoter of Notch target genes correlating with their transcriptional repression, which is reverted by TNFa (Aguilera et al., 2004) . Nevertheless, the mechanisms that regulate association of IkB to the chromatin and its repressive function remain unknown.
IkBa-deficient mice die around day 5 because of skin inflammation associated with high levels of IL1b and IFN-g in the dermis, CD8 + T cells, and Gr-1 + neutrophils infiltrating the epidermis, as well as altered keratinocyte differentiation (Beg et al., 1995; Klement et al., 1996; Rebholz et al., 2007) , similar to keratinocyte-specific IkBa-deficient mice (IkBa k5D/k5D ) (Rebholz et al., 2007) . In all cases, disruption of TNFa signaling rescued the skin phenotype (Shih et al., 2009) , suggesting that lethality was associated with an excessive inflammatory response, likely due to increased NF-kB activity. However, mice expressing different IkBa mutants that are equally able to repress NF-kB in the skin showed divergent phenotypes. Specifically, mice expressing the nondegradable IkBa mutant, IkBa S32-36A , developed skin tumors resembling SCC (van Hogerlinden et al., 1999) , whereas mice carrying a predominantly nuclear form of IkBa show no overt skin defects (WuerzbergerDavis et al., 2011) . Skin differentiation depends on the correct establishment and maintenance of specific gene expression patterns, including genes of the HOX family, which in the basal progenitor cells are repressed by EZH2, the catalytic subunit of the Polycomb repressive complex 2 (PRC2) (Ezhkova et al., 2009 (Ezhkova et al., , 2011 . PRC2 is composed by EZH2, the WD-repeat protein EED, RbAp48, and the zinc-finger protein SUZ12 (Zhang and Reinberg, 2001) . Methylation of lysine 27 on histone H3 (H3K27me3) by EZH2 imposes gene silencing in part by triggering recruitment of PRC1 (Cao et al., 2002; Min et al., 2003) and histone deacetylases (HDACs). Here, we investigate an alternative function for IkBa in the regulation of skin homeostasis, development, and cancer.
RESULTS

Phosphorylated and Sumoylated IkBa Localizes in the Nucleus of Keratinocytes
To investigate the physiological role for nuclear IkBa, we performed an initial screen to determine its subcellular distribution in human tissues. We found that IkBa localizes in the cytoplasm of most tissues and cell types as expected ( Figure S1A available online); yet, a distinctive nuclear staining of IkBa was found in human ( Figure 1A ) and mouse skin sections ( Figures 1A, S1A , and S1C), more prominently in the keratin14 + basal layer keratinocytes. IkBa distribution became more diffused in the suprabasal layer of the skin and gradually disappeared in the more differentiated cells. Specificity of nuclear IkBa staining was confirmed using skin sections from newborn IkBa-knockout (KO) mice ( Figure S1B ) and different anti-IkBa antibodies and blocking peptides ( Figure S1C ). By immunofluorescence (IF) and immunoblot (IB), we detected IkBa protein in both the cytoplasmic and the nuclear/chromatin fractions of human (Figures 1B and 1C) and mouse ( Figure S1D ) keratinocytes. Interestingly, nuclear IkBa displayed a shift in its electrophoretic mobility (z60 kDa) detected by different anti-IkBa antibodies, including the anti-phospho-S32-36-IkBa antibody. We next precipitated IkBa from nuclear and cytoplasmic keratinocyte extracts and determined whether this low IkBa mobility was a result of ubiquitin or SUMO modifications. We found that nuclear IkBa was specifically recognized by anti-SUMO2/3, but not anti-SUMO1 or anti-ubiquitin antibodies ( Figure 1D ; data not shown). Hereafter, we will refer to this nuclear IkBa species as phospho-SUMO-IkBa (PS-IkBa). By cotransfection of different SUMO plasmids in HEK293T cells, we demonstrated that SUMO2 was integrated to HA-IkBa at K21,22 ( Figure S1E ), independently of S32,36 phosphorylation ( Figure 1E ). By subcellular fractionation, we found that most HA-PS-IkBa was distributed in the nucleus of HEK293T cells (data not shown), and both K21,22R and S32,36A IkBa mutants showed reduced association with the chromatin ( Figure 1F ). These results suggest that phosphorylation and sumoylation are both required for IkBa nuclear functions in vivo. Of note, PS-IkBa levels were always low in HEK293T cells when It is well known that IKK activity regulates the cytoplasmic levels of IkBa. By double staining of skin sections, we found that the few cells that were positive for active IKK contained IkBa, but this IkBa was excluded from the nucleus ( Figure 1G ). To directly investigate whether IKK regulates subcellular distribution of IkBa, we transduced primary murine keratinocytes with lentiviral IKKa EE . We found that active IKKa induced a decrease in the nuclear levels of PS-IkBa as determined by IB ( Figure 1H ) and IF ( Figure S1G ). Additional experiments comparing the effects of both IKK isoforms demonstrated that IKKa EE was more efficient than IKKb EE in decreasing nuclear PS-IkBa levels (60% ± 5% compared with 16% ± 9% reduction; p < 0.001) ( Figure S1F ).
To directly address whether IkBa was required for normal skin differentiation, we performed IF analysis using different markers comparing IkBa wild-type (WT) and KO newborn skins. Consistent with previous reports, IkBa-deficient mice do not show any obvious skin defect at birth with a normal K5-positive basal layer, although we observed a slight reduction in the thickness of the K10-positive suprabasal epidermal layer. Most importantly, IkBa mutant skins showed a severe reduction of the more differentiated layer of cells identified by the accumulation of filaggrin granules ( Figure 1I ). This is a cause for impaired barrier function (Palmer et al., 2006) . Next, we aimed to distinguish between cellautonomous and non-cell-autonomous effects of IkBa deficiency by using an in vitro system for keratinocyte differentiation induced by high Ca 2+ exposure (Hennings et al., 1980) . In this model, we found that keratinocyte differentiation was associated with a decrease in both IkBa and PS-IkBa levels and activation of nuclear IKK ( Figures 1J and S1H) . Notably, knockdown (KD) of IkBa disturbs in vitro keratinocyte differentiation as indicated by the impaired K10 and filaggrin induction in response to Ca 2+ , which was accompanied by sustained expression of the progenitor marker p63 ( Figure 1K ). Together, these results strongly suggest that IkBa plays a cell-autonomous function in skin differentiation.
IkBa Directly Binds to the N-Terminal Tail of Histones H2A and H4 To further investigate the mechanisms underlying nuclear IkBa functions, we searched for nuclear proteins that directly associate with IkBa. Using GST-IkBa and human keratinocyte nuclear extracts in pull-down (PD) experiments, we isolated proteins of estimated molecular weights of 15 and 14 kDa that were identified by mass spectrometry as histones H2A and H4 (Figures 2A and 2B) . Interaction between histones H2A and H4
and IkBa was further confirmed by coprecipitation of endogenous proteins from keratinocyte nuclear extracts. Of note, the NF-kB subunit p65 was absent from nuclear IkBa precipitates but coprecipitated in the cytoplasmic fraction ( Figure 2C) . By PD assays, we determined the specificity of IkBa binding compared to other IkB homologs ( Figure 2D ) and mapped the IkBa-binding domain of histone H2A to be between amino acids 2 and 35 ( Figure 2E ). Preincubation of IkBa with p65 prevented its association with histones ( Figure S2A ), suggestive of mutually exclusive complexes.
Comparative sequence analysis of the IkBa-binding region of histone H2A (AA1-36) and the homologous region of H4 revealed the presence of a motif (3KXXXK/R) that was absent from other histone and nonhistone proteins ( Figure 2F ). To further study IkBa binding specificity, we screened a histone peptide array using nuclear HA-IkBa expressed in HEK293T cells as bait. We found that IkBa bound to peptides containing AA11-30 of histone H4, but not the corresponding region of histone H3. Most importantly, binding of IkBa to H4 was prevented by the combination K12/K16Ac and K20Ac or Me2 ( Figure 2G ). Because the equivalent peptides from histone H2A were not included in the array, we performed parallel precipitation experiments using biotin-tagged peptides (AA5-23) of histone H2A and H4 (Figures 2H and 2I) . We found that IkBa association was prevented by K12Ac, K16Ac, and K20me2 of histone H4 or the equivalent modifications of the H2A peptide ( Figure 2H ) and also when all K/R residues in the 3KXXXK motif were changed into A ( Figure 2I ). Of note that in these experiments histone-bound HA-IkBa was mostly identified as a nonsumoylated band, which opens the possibility that posttranslation modifications are not essential to mediate this interaction in vitro. However, parallel binding experiments using keratinocyte extracts, PS-IkBa, showed a preferential binding to the histone peptides compared with the cytoplasmic 37 kDa IkBa form ( Figure S2B ). Together, these results strongly suggest that only PS-IkBa can bind the chromatin, but in HEK293T cells this molecule is then desumoylated in vivo or as a consequence of the experimental processing.
To gain further insights into the molecular basis of IkBa binding to histones, we completed the structure of IkBa obtained from the Protein Data Bank (ID code 1IKN), which lacked part of the ankyrin repeat (AR) 1, using RAPPER (Depristo et al., 2005) and performed docking studies with AutoDock Vina (Trott and Olson, 2010) of the histone H4 peptide, GKGGAKRHRKV, that contains most of the KXXXK domain. Docking calculations showed two deep pockets for K interaction in IkBa located between ARs 1-2 and 2-3 and an additional shallower patch between AR3 and 4. Overall, the peptide bound in a clearly negative region on the IkBa surface ( Figure 2J ), with higher affinity than the modified peptide that was acetylated in the first and (legend continued on next page)
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IkBa Is a Modulator of Polycomb Function second K residues (K12 and K16). We experimentally validated that ARs of IkBa participate in histone binding because the IkBaD55-106 mutant, lacking part of AR1, failed to bind GST-H2A ( Figure S2C ). Similarly, this association was prevented by 1% deoxycholate (Figure S2D ), as described for interactions involving the ARs of IkBa (Baeuerle and Baltimore, 1988; Savinova et al., 2009 ).
IkBa Is Specifically Recruited to the Regulatory Regions of Developmental Genes
To identify putative PS-IkBa target genes, we performed chromatin immunoprecipitation sequencing (ChIP-seq) using chromatin extracts from primary human keratinocytes and antiIkBa antibody. We identified 2,778 enriched peaks, corresponding to 2,433 Ensembl genes that were significantly enriched with p values % 10 À5 . Gene ontology analysis showed that a significant proportion of genes participate in biological processes associated with embryonic development and cell differentiation. IkBa targets included genes of the HOX and IRX families, ASCL4, CDX2, NEUROD4, OLIG3, and NEURL, among others ( Figures  3A and 3B) . Annotation of the peak genomic positions to the closest gene demonstrated that many peaks were positioned immediately after the transcription start site (TSS), with a sharp decrease near the transcription termination site (TTS) ( Figure 3C ), whereas others were located far from promoter regions. Some of the latter overlapped with regions enriched in H3K4me1, a histone mark associated with enhancer regions (data not shown). Randomly selected IkBa targets were confirmed by conventional chromatin immunoprecipitation (ChIP) using primers flanking the regions identified in the ChIP-seq experiment ( Figure 3D ). Consistent with its overall effects on IkBa levels, sustained Ca 2+ treatment caused the loss of IkBa from all tested gene promoters ( Figure 3E ). Similarly, short treatment with TNFa released chromatin-bound IkBa in keratinocytes, as we previously found in fibroblasts (Aguilera et al., 2004) . However, we did not detect a general effect of TNFa on PS-IkBa levels, but we consistently found a partial redistribution of PS-IkBa to the soluble nuclear fractions ( Figure S3A ). Next, we investigated whether TNFa and Ca 2+ modulated HOX and IRX transcription in keratinocytes.
All tested IkBa targets (n = 12) were robustly induced by TNFa treatment (up to 12-fold) following different kinetics (Figures 3F) and to a lesser extent (up to 3-fold) by Ca 2+ treatment (Figure S3B) or IkBa KD ( Figure S3C ). Interestingly, 1 hr of TNFa treatment prevented Ca 2+ -induced differentiation of murine keratinocytes ( Figure S3D ), supporting the notion that PS-IkBa integrates inflammatory signals with skin homeostasis (see Discussion). We also tested whether p65 participated in HOX or IRX gene activation by TNFa. By ChIP analysis, we did not find any recruitment of p65 to IkBa target genes after TNFa treatment, in contrast to a canonical NF-kB target gene promoter (Figure S3E) . However, we detected low amounts of p65 at HOX genes under basal conditions that might contribute to gene repression (Dong et al., 2008) , although the function of chromatin-bound p65 at regions distant from the TSS of both NF-kB targets and nontargets is unresolved. Binding of p65 to HOX and IRX was reduced after TNFa treatment, suggesting that p65 was redistributed from noncanonical to canonical NF-kB targets once activated.
Silencing of HOX genes in keratinocytes involves PRC2 and its core component the H3K27 methyltransferase EZH2 (Ezhkova et al., 2009; Mejetta et al., 2011) . To explore a putative association between IkBa and PRC2 function, we crossed our list of 2,433 IkBa targets with available ChIP-seq data from keratinocytes. Approximately 50% of IkBa targets corresponded to genes enriched for the H3K27me3 mark ( Figures 3G and S3F ), although IkBa targeted only 13% of the H3K27 trimethylated genes. Most importantly, genomic sequences occupied by IkBa essentially overlapped with those regions containing high H3K27me3 levels ( Figure 3G ). We also found a statistically significant overlap (p < 10 À16 ) between IkBa target genes and PRC targets in ES cells (Birney et al., 2007; Ku et al., 2008 ) ( Figure S3G ).
IkBa Interacts with and Regulates Association of PRC2 to Target Genes in Response to TNFa
In the mass spectrometry analysis of proteins that associate with GST-IkBa, we identified a few peptides corresponding to chromatin modifiers, such as EZH2 and SUZ12, and SIN3A ( Figure  S4A ). Specificity of IkBa interactions with PRC2 elements, but also IkBa association to the PRC1 protein BMI1, was confirmed by PD assays ( Figure S4B ). SUZ12 was able to interact with nuclear IkBa, whereas p65 specifically associated with cytoplasmic IkBa in the IP experiments ( Figure 4A ). Importantly, exogenous wild-type IkBa, but not an IkBa mutant that failed to bind histones, facilitated the association of SUZ12 to GST-H4 ( Figure 4B) . Moreover, ChIP experiments demonstrated that TNFa treatment induced the dissociation of SUZ12 from IkBa target regions, but not non-IkBa targets ( Figure 4C ). Sequential ChIP experiments demonstrated that IkBa and SUZ12 simultaneously bound to IkBa target genes ( Figure 4D ). To test the functional relevance of IkBa in PRC-mediated repression, we used WT murine embryonic fibroblast (MEFs), which expressed detectable levels of PS-IkBa ( Figure 4E) and IkBa KO MEFs. By ChIP-on-chip experiments using three different IkBa antibodies, we confirmed that several Hox genes were also targets of IkBa in MEFs (Table S1 ). By ChIP, we found that SUZ12 and EZH2 bound IkBa targets efficiently in WT MEFs (legend continued on next page)
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IkBa Is a Modulator of Polycomb Function but only weakly in IkBa KO MEFs ( Figure 4F , time 0). In WT cells, TNFa treatment induced a significant but temporary release of SUZ12 and EZH2 from these loci, which peaked after 30-60 min of treatment ( Figure 4F ). The binding of PRC2 proteins at Hox genes inversely correlated with the expression of these Hox genes ( Figure 4G ). In contrast, IkBa KO cells failed to activate Hox transcription in response to TNFa ( Figure 4G ), which is consistent with a defective release of PRC2 proteins ( Figure 4F ). Unexpectedly, we did not detect changes in H3K27me3 levels in these Hox genes upon TNFa treatment at any of the time points studied (20 min, 2 hr, and 7 hr) (data not shown), likely reflecting the high stability of this histone modification (De Santa et al., 2007) . Supporting the possibility that activation of IkBa targets is independent of the enzymatic activity of EZH2, a 24 hr treatment with the EZH2 inhibitor DZNep does not affect Hoxb8 or Irx3 messenger RNA (mRNA) levels in keratinocytes (data not shown). Together, these results suggest that transcriptional repression-activation of these genes does not strictly depend on EZH2 enzymatic activity but rather PRC2 release might modulate the dissociation of PRC1 or HDACs (van der Vlag and Otte, 1999) that associate with more dynamic chromatin modifications. In agreement with this possibility, histone H3 is rapidly acetylated following TNFa treatment at different Hox gene promoters ( Figure S4C ). To further study the involvement of NF-kB in the regulation of IkBa targets by TNFa, we attempted to use different mutant MEFs, including the p65, Ikka, Ikkb, and the triple p65;p50;cRel KO. We found that TNFa induced Hox and Irx expression in both p65 and Ikkb KO cells ( Figure S4D ) suggesting that it was NF-kB independent. However, specific mutants contained variable levels of IkBa and PS-IkBa ( Figures S4E and S4F ), which make a more accurate quantitative analysis unproductive. Interestingly, phosphorylation of nuclear IkBa was not reduced in the Ikka or Ikkb KO cells (Figures S4F), indicating that other kinases are involved in generating PS-IkBa. Only triple KO cells, which essentially lacked IkBa ( Figure S4G ) and the Ikka-deficient MEFs, showed a strong defect on Hox and Irx transcription ( Figures S4D and S4H ). To better understand the contribution of NF-kB to Hox regulation, we next performed luciferase reporter assays measuring the ability of different IkBa mutant proteins to repress a Hoxb8-promoter construct compared with a reporter containing three consensus sites for NF-kB (3xkB). We found that WT IkBa and the nuclear IkBa NES mutant (Huang et al., 2000) significantly repressed both promoters. However, mutations that affect chromatin-association ( Figure 1F ) prevented Hoxb8 repression but still inhibited the expression of the 3xkB reporter ( Figure 4H ). Consistently, Hoxb8 mRNA levels were significantly reduced in the skin of mice expressing IkBa NES (Wuerzberger-Davis et al., 2011) ( Figure 4I ). Moreover, these animals showed an expansion of the K14-positive basal layer of keratinocytes containing nuclear IkBa ( Figure 4J ), associated with increased proliferation measured by ki67 staining and impaired differentiation as indicated by the reduced thickness of the suprabasal K10-expressing layer ( Figure 4K ).
Genetic Interaction between IkBa/cactus and polycomb in Drosophila Polycomb group (PcG) IkB and NF-kB proteins are conserved from flies to humans. In addition, Drosophila contains one Hox cluster, compared with four clusters in vertebrates, which facilitates studying genetic interactions. We first confirmed that the single Drosophila IkB homolog, cactus (cact) (Geisler et al., 1992) , maintained the capacity to associate with histones ( Figure 5A ). By IF, we detected colocalization of cactus and Polycomb (Pc), a PRC1 protein that is essential for the repressive PRC2 function, in specific bands of polytene chromosomes ( Figure 5B ). Most of the cactus staining overlapped with Pc, but only a few Pc-positive bands contained cactus. Based on our mammalian data, our first attempt was to generate single PRC2 mutants and combine them with cactus-deficient mutants. All mutants were tested in heterozygosis because homozygous mutations in cactus or PcG genes are lethal. We found that heterozygous mutations in PRC2 genes (e.g., the null mutations of E(z)) as well as the composed E(z) and cact exhibit no overt homeotic phenotypes. In contrast, heterozygous Pc mutants exhibit a variety of characteristic homeotic transformations, including the partial transformation of the second and third (mesothoracic and metathoracic) legs toward first (also known as prothoracic) legs that in males are characterized by the presence of sex combs. Modifications of this phenotype (also called ''extra sex comb'') have been extensively used as a functional assay to validate new PcG proteins in vivo. Thus, we tested the effect of reducing cact on Pc-induced homeotic transformation using 12 recessive mutations of cact and two independently generated Pc alleles. All cact mutant alleles, but more prominently cact 1 , enhanced the ''extra sex comb'' phenotype of Pc mutations (Pc 3 and Pc XT109 ) ( Figure 5C ; Table S2 ).
Because cells lacking cact exhibit massive nuclear localization of the transcription factor dorsal (dl, Drosophila NF-kB/Rel/p65 ortholog) during postembryonic stages (Lemaitre et al., 1995) , we tested whether enhancement of homeotic defect of Pc by cact mutations is due to increased dorsal activity. Because stability of cact is under NF-kB/Dorsal control (Kubota and Gay, 1995) , we anticipated that for phenotypes due to increased dorsal, dl mutations would counteract cact mutations, whereas for phenotypes independent of dorsal, reducing dl should yield See also Figure S4 and Table S1 .
IkBa Is a Modulator of Polycomb Function phenotypes similar to that of cact mutants. We found that heterozygous dl mutations significantly enhanced the extra sex comb transformation phenotype of Pc heterozygotes (Table S3) , similar to the effect of cact mutations. Furthermore, by generating triple heterozygous strains carrying the null allele of dorsal (dl 1 ), the Pc XT109 allele and different cact alleles, we found that most of the triple heterozygous cact;dl;Pc exhibited similar or stronger homeotic phenotypes than double heterozygotes for dl;Pc and cact;Pc of a particular allelic combination ( Figures  5D and 5E ). Note that the smaller number of animals scored in the triple heterozygotes also reflects the higher lethality of this genotype. These data support our finding that IkB/cactus Tables S2 and S3. cooperates with Polycomb-mediated repression, independently of NF-kB/dorsal, which is relevant for the regulation of epidermal development in the fly.
Requirement of IkBa for Keratinocyte Transformation and HOX Upregulation
Deregulated HOX expression is a common trait in cancer (De Souza Setubal Destro et al., 2010; Hassan et al., 2006; Yamatoji et al., 2010; Zhai et al., 2007) , including squamous cell carcinoma (SCC). To study whether IkBa participates in Hox deregulation of SCC, we induced transformation of primary murine keratinocytes by expressing mutant H-RasV12 plus DNp63a using retroviral infection (Keyes et al., 2011) . We found that PS-IkBa, which was consistently detected in the nuclear fraction of control-transduced keratinocytes, was mainly lost in transduced cells associated with P-IKK induction ( Figure 6A ). By ChIP assay, we found that binding of SUZ12 and EZH2 at IkBa targets was significantly decreased in these cells ( Figure 6B ), concomitant with a massive increase in IkBa target gene expression ( Figure 6C ). Furthermore, transformed keratinocytes growing in three-dimensional (3D) matrigel cultures showed a complete cytoplasmic distribution of IkBa ( Figure 6D ), whereas IkBa KD abrogated the capacity of transformed keratinocytes to grow in matrigel (Figure 6E) , similar to the nontransformed cells. These results suggest that accumulation of cytoplasmic IkBa favors oncogenic transformation. We further explored this possibility by analyzing the subcellular distribution of IkBa protein in a tissue microarray (TMA) that included different human nonmalignant or premalignant skin lesions (n = 21), skin cancer (n = 32), and normal control samples (n = 3). We detected nuclear IkBa in different nonmalignant/noninflammatory lesions and normal skin samples. In noninvasive tumors, such as actinic keratosis and Bowen's disease, a variable proportion of cells displayed localization of IkBa in the cytoplasm, but most of them retained nuclear IkBa, including chromosomal staining of the mitotic keratinocytes ( Figure 6H ). In more aggressive cutaneous SCC, around 50% of the tumor cells showed a complete loss of nuclear IkBa and accumulation of cytoplasmic IkBa (Figures 6F and  6G) . By qRT-PCR, we measured the mRNA levels of several IkBa targets in 21 SCC and 13 normal skin samples. We found that HOXD3 was significantly increased in human SCC compared with normal skin (p = 0.04). We also detected a consistent upregulation of HOXB9 and HOXB5 that did not reach statistical significance due to the dispersion between samples ( Figure 6I ; data not shown).
We extended our study to a cohort of 112 patients with urogenital SCC at different stages of tumor progression. We found that cytoplasmic IkBa accumulation started before the stage of tumor invasion, but total loss of nuclear IkBa was most predominant in the invasive areas of the tumors and in the metastases. The significance of the correlations was p < 0.0001 for normal adjacent versus in situ tumor, p < 0.0001 for in situ compared with infiltrating tumors, and p = 0.3 when comparing the tumor with the metastasis, using the Fisher's exact test (Figures 6J and 6L ). Cytoplasmic accumulation of IkBa significantly associated with IKKa activation in these samples ( Figures 6K  and 6L ).
DISCUSSION
Here, we show that IkBa plays a function in the chromatin associated with repression of developmental genes, including the HOX and IRX families. We focused our study on the skin keratinocytes, where we found a significant accumulation of nuclear IkBa; however, this mechanism is not exclusive of this cell type and operates at least also in fibroblasts. In addition, we deciphered part of the mechanism of IkBa-mediated repression that involves posttranslational IkBa modifications and association with histones H2A/H4 and Polycomb proteins. The evolutionary conservation of this mechanism is illustrated by the strong homeotic phenotype of double Polycomb and cactus mutants in Drosophila.
Compiled data on NF-kB signaling demonstrate that IkBa plays a major role as inhibitor of the p65/p50 dimer and termination of NF-kB signal after stimulation. In the latter, establishment of a nuclear IkBa-NF-kB transient ternary complex actively facilitates dissociation of NF-kB from specific binding sites in the DNA (Zabel and Baeuerle, 1990) , leading to the notion that IkBa and chromatin binding are irreconcilable. Our experiments demonstrate that a specific fraction of IkBa that is phosphorylated at S32,36 and posttranslationally modified by SUMO2 at K21,22 is able to bind the histones. Sumoylation of IkBa had been previously described, but the functional relevance of this modification was mainly unknown (Desterro et al., 1998) . Although phosphorylation of S32,36 is the instructive mark that targets IkBa for K21,22 ubiquitination and its subsequent degradation by the proteasome, we now propose that K21,22 sumoylation protects phosphorylated IkBa from degradation, thus generating an unexpected functional IkBa species. Whether calcium-induced degradation of PS-IkBa involves its desumoylation and subsequent ubiquitylation, and which modifications in both IkBa and histones are imposed by TNFa and induce PSIkBa release from the chromatin, is currently under investigation.
Our data suggest that other IkB homologs cannot compensate IkBa chromatin function because Hoxb5 and Hoxb8 failed to be induced by TNFa in IkBa KO cells. However, expression of IkBb from the IkBa locus compensates most of the defects of IkBa deficiency (Cheng et al., 1998) , which suggest that a specific fraction of IkBb (i.e., hypophosphorylated nuclear IkBb) might overlap nuclear IkBa functions in the skin or that ectopic IkBb affects regulation of cytokines that mediate lethality in IkBa KO models (Rebholz et al., 2007) . It is the strong association between inflammation and the skin phenotype that has impaired distinguishing between cell-autonomous and non-cell-autonomous effects of IkBa deletion on keratinocyte differentiation. Our data indicate that IkBa plays an essential role in this process, as shown by the strong decrease in the number of Filaggrinexpressing cells in the skin of IkBa KO newborn mice, which results in a defective skin barrier that might explain the massive inflammatory response observed in these animals after cytokine exposure. Moreover, this function is cell autonomous as indicated by our in vitro data. However, in transformed keratinocytes and human SCC, IkBa is accumulated in the cytoplasm associated with tumor progression and increased HOX expression, which is consistent with the tumorigenic phenotype of mice expressing the chromatin binding-defective IkBa super-repressor mutant in the skin (Dajee et al., 2003 ; van Hogerlinden et al., 
Cancer Cell
IkBa Is a Modulator of Polycomb Function 1999 . We propose that accumulation of IkBa in the cytoplasm, or even in the nucleoplasm as it is observed after TNFa exposure, contributes to gene activation by sequestering nuclear repressors. In contrast, knockin mice carrying a nuclear IkBa mutant do not show defective skin function or signs of SCC, even in aged mice (data not shown). Although we cannot exclude the involvement of NF-kB in the IkBa mutant phenotypes, these reports and our data support the concept that nuclear IkBa through Hox/Irx regulation might provide a platform to integrate control of barrier integrity with cytokine response, while preventing cell transformation.
On the other hand, extensive in silico analysis of the IkBa target promoters failed to reveal any enrichment of specific sequences that could mediate binding specificity, which is coherent with the absence of known DNA elements that recognize PRC2 in mammalian genes and is different from Drosophila genes that contain PRE elements (Simon et al., 1993) . Instead, our data show that IkBa binds the chromatin in regions enriched for H3K27me3, which is antagonized by specific combinations of histone H2A/H4 modifications. Such H2A/H4 modifications are involved in skin differentiation (Frye et al., 2007) and are known to regulate chromatin structure (Kimura et al., 2002; ShogrenKnaak et al., 2006; Suka et al., 2002) , which could be connected with the IkBa function described here.
Based on our results, we propose a model ( Figure 7 ) in which nuclear PS-IkBa negatively regulates transcription of developmentally related genes in collaboration with Polycomb proteins. Keratinocyte differentiation or TNFa treatment result in the loss of chromatin-associated IkBa and Polycomb release, associated with a moderate or temporary activation of Hox and Irx transcription, respectively. Upon oncogenic transformation, nuclear IkBa is lost, but it accumulates in the cytoplasm, leading to a massive activation of Hox and Irx genes, likely related with cytoplasmic retention of negative regulators of gene transcription (Aguilera et al., 2004; Viatour et al., 2003) . Future studies will focus on establishing the exact histone code that is recognized by IkBa and the elements involved in its regulation, both in physiological and pathological situations. In brief, sumoylated and phosphorylated IkBa binds the chromatin of noninduced and nontransformed cells to maintain gene repression, which is relieved after cytokine induction or keratinocyte transformation. Release of IkBa from the chromatin is, at least in part, mediated by IKKa and results in PRC dissociation and specific gene activation. These effects are maximized by stimuli that lead to tumorigenesis.
Animal Care Committee of Generalitat de Catalunya, USCD and University of Wisconsin approved all procedures.
Cell Fractionation
Cells were lysed in 10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.05% NP40 at pH 7.9 for 10 min on ice and spun at 3,000 rpm. Supernatants were the cytoplasmic fraction. Pellets were lysed in 5 mM HEPES, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 26% glycerol at pH 7.9, sonicated 5 s three times, left on ice 20 min, and then centrifuged 15 min at 13,000 rpm to recover the soluble nuclear fractions. Pellets included the nonsoluble chromatin-enriched fraction.
Coimmunoprecipitation Assay and Peptide Array
For precipitation of nuclear extracts, nuclei were either crosslinked with dithiobis succinimidyl propionate (DSP, Pierce) 15 min at room temperature and then sonicated in a bioruptor (Diagenode) in 1% SDS-containing buffer and then neutralized by 1% Triton X-100, or directly sonicated in RIPA buffer plus protease inhibitor cocktail (Roche) and 10 mM N-ethyl maleimide. In both cases, nuclear lysates were centrifuged at 13,000 rpm for 15 min and then incubated with 5 mg of the indicated antibodies. Precipitates were captured with 35 ml of protein A-sepharose, extensively washed, and analyzed by IB. In most of the experiments, we used the Clean-Blot IP Detection Kit instead of standard secondary antibodies, which is optimized for postimmunoprecipitation IB. Histone peptides were synthesized as biotinylated N-terminal and C-terminal amides (Peptides and Elephants). Peptides were incubated overnight at 4 C with the indicated cell extracts and precipitated with streptavidin-sepharose beads (Amersham) for 45 min. Denatured HEK293T nuclear extracts were used to hybridize a histone peptide array from Active Motif (N.13001). Peptide composition can be found at http://www.activemotif.com/catalog/667/ histone-peptide-array and includes different combinations of acetylated, methylated, or unmodified peptides.
Chromatin Immunoprecipitation, ChIP-on-Chip, and ChIP-Seq Cells were subjected to chromatin immunoprecipitation (ChIP) as previously described (Aguilera et al., 2004) . Briefly, formaldehyde crosslinked cell extracts were sonicated, and chromatin fractions were incubated with sc-371, sc-371G, sc-1643 (Santa Cruz Biotechnology), or 06-494 (Upstate) anti-IkBa antibodies in RIPA buffer and precipitated with protein A/G-sepharose (Amersham). Crosslinkage was reversed, and DNA was analyzed by PCR, sequenced, or labeled to hybridize the Mouse BCBC PromoterChip 5 from the University of Pennsylvania School of Medicine (http://www.cbil.upenn. edu/EPConDB/). Data obtained were analyzed with AFM 4.0 software (Breitkreutz et al., 2001) . Anti-IkBa antibody 06-494 (Upstate) was used for ChIP-seq, and 6 ng of precipitated chromatin from human keratinocytes was directly sequenced in these experiments. Data are deposited at the GEO database with accession numbers GSM744581 and GSE24011. For mapping, peak calling, and functional enrichment analysis, see the Supplemental Experimental Procedures.
ACCESSION NUMBERS
The GEO accession number for the ChIP-on-chip and ChIP-seq reported in this paper are GSM744581 and GSE24011, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, four figures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.ccr.2013.06.003.
